| HOME >> BIOLOGY >> TECHNOLOGY |
Accounts receivable (1,311,112) 364,504
Inventories, net (1,007,321) (726,258)
Other current assets 32,162 (123,837)
Accounts payable and accrued liabilities 729,777 506,264
Other non-current assets and liabilities (13,413) 241,421
Net cash used in operating activities (3,828,482) (2,958,570)
Cash flows from investing activities:
Purchases of property & equipment, net (832,031) (526,071)
Purchases of available-for-sale securities (1,535) (6,761)
Maturities of available-for-sale securities 5,100,000 1,808,000
Net cash provided by investing activities 4,266,434 1,275,168
Cash flows from financing activities:
Payments on long-term debt and capital lease
obligations (523,063) (94,936)
Proceeds from stock option exercises 111,699 126,241
Net cash (used in) provided by financing
activities (411,364) 31,305
Effect of exchange rate changes on cash (12,661) (52,145)
Net change in cash and cash equivalents 13,927 (1,704,242)
Cash and cash equivalents - beginning of
period 13,000,652 14,890,383
Cash and cash equivalents - end of period $13,014,579 $13,186,141
| SOURCE AtriCure, Inc. Copyright©2008 PR Newswire. All rights reserved |